Global Home Global Home  
 
 

 

 

Quarterly Results

2018

Hide / Show Second Quarter 2018
News Release
Press release Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million
SEC Filing
SEC filing Form 10-Q
Hide / Show First Quarter 2018

2017

Hide / Show Fourth Quarter 2017
Hide / Show Third Quarter 2017
Hide / Show Second Quarter 2017
Hide / Show First Quarter 2017

2016

Hide / Show Fourth Quarter 2016
Hide / Show Third Quarter 2016
Hide / Show Second Quarter 2016
Hide / Show First Quarter 2016

2015

Hide / Show Fourth Quarter 2015
Hide / Show Third Quarter 2015
Hide / Show Second Quarter 2015
Hide / Show First Quarter 2015

Disclaimer
The press releases, presentations and printed reports on our website are included for historical purposes only. The information in these documents should be considered accurate only as of the date of document. We disclaim any obligation to supplement or update the information in these documents.